Duration of antibiotic treatment and risk of recurrence after surgical management of orthopaedic device infections: a multicenter case-control study

Table 4 Results of multiivariate logistic regression regression analysis, infected ORIF constructs only

Variable	Logistic regression, OR (95% CI)	p
Age (quartiles)
Male gender	0.94 (0.541–1.63)	0.641
ASA	1.52 (0.53–4.34)	0.706
MSSA present	1.26 (0.48–3.31)	0.598
MRSA present	3.84 (1.29–11.41)	0.661
CNS present	2.16 (0.36–13.13)	0.734
Duration of fluoroquinolone treatment (categorized)	0.31 (0.06–1.67)	0.924
Duration of rifampicin treatment (categorized)	0.67 (0.23–11.98)	0.495
Interaction	0.17 (0.01–5.45)	0.956

ASA American Society of Anesthesiologists physical status classification system, MSSA methicillin-sensitive staphylococcus aureus spec, MRSA methicillin-resistant staphylococcus aureus spec, CNS coagulase-negative staphylococci

ISSN: 1471-2474